Literature DB >> 21310035

Solitary splenic metastasis from ovarian carcinosarcoma: a case report.

Alex B Olsen1, Sabine Pargman, Thomas Gillespie.   

Abstract

INTRODUCTION: Metastatic tumors to the spleen are rare but are usually found in conjunction with metastasis to other organs. The most common sources of splenic metastasis are breast, lung and colorectal cancers as well as melanoma and ovarian carcinoma. A solitary carcinosarcoma metastasis to the spleen of any origin is very rare. To the best of our knowledge, there are fewer than 30 reported cases of ovarian primary tumors with solitary metastasis to the spleen, and only three solitary primary carcinosarcomas to the spleen have been reported, of which one is female. We present what is, to the best of our knowledge, the first case of a solitary metastatic carcinosarcoma to the spleen arising from a primary ovarian carcinsarcoma. CASE
PRESENTATION: A 72-year-old Hispanic woman status post-total abdominal hysterectomy for ovarian carcinosarcoma presented with complaints of early satiety and abdominal pain for the past two months with a 30-lb unintentional weight loss. An initial computed tomographic scan of her abdomen and pelvis revealed a 30 cm × 27 cm splenic mass with displacement of the left kidney, stomach and liver. The patient was found to have a solitary metastatic carcinosarcoma of the spleen with biphasic epithelial (carcinomatous) and mesenchymal (sarcomatous) elements consistent with carcinosarcoma.
CONCLUSION: Carcinosarcoma of the spleen is a rare tumor. Carcinosarcomas are a biphasic neoplasm comprising malignant epithelial and mesenchymal components arising from a stem cell capable of differentiation. They can arise anywhere in the female genital tract, most commonly from the endometrium. Even though it is rare, carcinosarcomas can metastasize to the spleen. This unique case of a solitary splenic metastasis from ovarian carcinosarcoma has particular interest in medicine, especially for the specialties of surgical oncology, pathology and hematology/oncology.

Entities:  

Year:  2011        PMID: 21310035      PMCID: PMC3045934          DOI: 10.1186/1752-1947-5-56

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  14 in total

1.  Pancreatic mucinous cystic neoplasms with sarcomatous stroma: molecular evidence for monoclonal origin with subsequent divergence of the epithelial and sarcomatous components.

Authors:  W van den Berg; M Tascilar; G J Offerhaus; J Albores-Saavedra; B M Wenig; R H Hruban; E Gabrielson
Journal:  Mod Pathol       Date:  2000-01       Impact factor: 7.842

2.  Splenectomy for splenic metastases: a changing clinical spectrum.

Authors:  S S Lee; L Morgenstern; E H Phillips; J R Hiatt; D R Margulies
Journal:  Am Surg       Date:  2000-09       Impact factor: 0.688

3.  Metastatic tumors to the spleen: a 25-year clinicopathologic study.

Authors:  K Y Lam; V Tang
Journal:  Arch Pathol Lab Med       Date:  2000-04       Impact factor: 5.534

Review 4.  Gallbladder carcinosarcoma: a case report and literature review.

Authors:  Kevin L Huguet; Christopher B Hughes; Winston R Hewitt
Journal:  J Gastrointest Surg       Date:  2005 Jul-Aug       Impact factor: 3.452

5.  Solitary splenic metastasis of ovarian cancer.

Authors:  Naoto Furukawa
Journal:  Arch Gynecol Obstet       Date:  2006-11-10       Impact factor: 2.344

6.  Cisplatin as second-line therapy in ovarian carcinoma treated initially with single-agent paclitaxel: a Gynecologic Oncology Group study.

Authors:  J Tate Thigpen; John A Blessing; George Olt; Samuel S Lentz; Jeffrey Bell
Journal:  Gynecol Oncol       Date:  2003-09       Impact factor: 5.482

7.  Carcinosarcoma of the ovary treated with platinum and taxane: the memorial Sloan-Kettering Cancer Center experience.

Authors:  Aliza L Leiser; Dennis S Chi; Nicole M Ishill; William P Tew
Journal:  Gynecol Oncol       Date:  2007-03-28       Impact factor: 5.482

8.  Paclitaxel and platinum chemotherapy for malignant mixed müllerian tumors of the ovary.

Authors:  Linda R Duska; Audrey Garrett; Gamal H Eltabbakh; Esther Oliva; Richard Penson; Arlan F Fuller
Journal:  Gynecol Oncol       Date:  2002-06       Impact factor: 5.482

9.  Carcinosarcoma of the spleen. An extragenital malignant mixed müllerian tumor?

Authors:  W H Westra; B O Anderson; D S Klimstra
Journal:  Am J Surg Pathol       Date:  1994-03       Impact factor: 6.394

Review 10.  Carcinosarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics.

Authors:  Lauren E Kernochan; Rochelle L Garcia
Journal:  J Natl Compr Canc Netw       Date:  2009-05       Impact factor: 11.908

View more
  4 in total

1.  Splenectomy for splenic metastases from malignant adrenal pheochromocytoma: a case report.

Authors:  Xiao-Feng Duan
Journal:  Cancer Biol Med       Date:  2013-06       Impact factor: 4.248

2.  Primary malignant mixed müllerian mesodermal tumor mimicking a rectosigmoid carcinoma: a case report and review of the literature.

Authors:  Sakshi Kapur; Levin Miles
Journal:  Case Rep Oncol Med       Date:  2014-02-10

3.  Splenic metastasis of ovarian clear cell adenocarcinoma: A case report and review of the literature.

Authors:  Meiling Lv; Yuyao Li; Changqin Luo; Peijun Liu; Jin Yang
Journal:  Exp Ther Med       Date:  2014-01-24       Impact factor: 2.447

4.  Solitary splenic metastasis of ovarian carcinoma: a case report.

Authors:  Dror Karni; Doron Kopelman; Ossama Abu Hatoum
Journal:  J Med Case Rep       Date:  2014-05-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.